Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $53.8567 (1.01%) ($52.8501 - $53.9185) on Wed. Nov. 18, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 72 | Latest Price | $53.8567(1.01%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(48%) IBB(47%) IVE(47%) SPY(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.42% in a week (0% probabilities). VIXM(-21%) TLT(-14%) UUP(-9%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $53.24(1.16%) | 10 Day Moving Average | $54.22(-0.67%) | 20 Day Moving Average | $52.04(3.49%) | To recent high | -10.6% | To recent low | 26.4% | Market Cap | $95.018b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |